To further validate the impact of SIX1 on breast cancer stem cells and ensure the integrity and reliability of our experiments, we utilized two cell lines: murine breast cancer cell line 66cl4 and human breast cancer cell line MCF-7. The gene discussed is SIX1; the disease is breast cancer.